[225ac]ac-aky-1189
·Code: AKY-1189
[225ac]ac-aky-1189: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Aktis Oncology Inc. (AKTS) | Phase 1 |
Clinical Trials (1)
NECTINIUM-2: A Phase 1b, 2 Part, Multicenter, Single Arm, Open Label Study to Evaluate the Safety and Efficacy of a Nectin-4 Radiopharmaceutical ([225Ac]Ac-AKY-1189) in Patients With Previously Treated Locally Advanced or Metastatic Solid Tumors
Frequently asked questions
Who is developing [225ac]ac-aky-1189?
[225ac]ac-aky-1189 is being developed by Aktis Oncology Inc..
How many clinical trials involve [225ac]ac-aky-1189?
BioSniper tracks 1 clinical trial involving [225ac]ac-aky-1189.
Get deeper analysis on [225ac]ac-aky-1189
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis